Dr. Michael Rome joined Foresite Capital in 2016 and leads the therapeutics investing…
Foresite Capital Fellows top row L-R: Ang Cui, Charlie Lee, Chase Kelley, Justin Lee, Rasa Elmentaite…
Today we are pleased to announce Foresite Capital’s investment in ImmPACT Bio, which we co-led with Venbio and Decheng Capital. We’re excited about ImmPACT’s focus on next generation cancer therapies based on transformative…
By Jim Tananbaum, Founder, CEO & Managing Director